The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

The latest of those is a bid valued at up to $10 billion for U.S. obesity-drug developer Metsera, up from a previous $9 billion offer it originally made, as it tries to usurp an already agree-on deal ...

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

Dancing With the Stars contestant Andy Richter shared his thoughts on the commentary about his weight that has followed him throughout his decades in the public eye.

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

New research shows that a new weight-loss drug called MariTide might offer a powerful alternative to current weekly ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

When his plane touched down in Sydney, Jelly Roll instantly drew attention with a look, which was the result of an overhaul he'd completed just before the kickoff of his first Australian headline tour ...